| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9872409 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages | 
Abstract
												Conclusions: Thymidine phosphorylase expression or COX-2/TP coexpression may be used as a molecular prognostic marker for squamous cell carcinoma of the uterine cervix. TP appears to be an important downstream molecule of COX-2 during angiogenesis and may be a new target for the treatment of uterine cervical cancer.
											Keywords
												
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Hongryull M.D., Yong Bae M.D., Nam Hoon M.D., Chang Ok M.D., Tchan Kyu M.D., Yeon Sook Ph.D., Gwi Eon M.D., 
											